Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 353 GBX 1.58% Market Closed
Market Cap: 374.2m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Wall Street
Price Targets

OXB Price Targets Summary
Oxford BioMedica PLC

Wall Street analysts forecast OXB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OXB is 526.32 GBX with a low forecast of 383.8 GBX and a high forecast of 840 GBX.

Lowest
Price Target
383.8 GBX
9% Upside
Average
Price Target
526.32 GBX
49% Upside
Highest
Price Target
840 GBX
138% Upside
Oxford BioMedica PLC Competitors:
Price Targets
2171
CARsgen Therapeutics Holdings Ltd
52% Downside
SYRE
Spyre Therapeutics Inc
247% Upside
PRAX
Praxis Precision Medicines Inc
98% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
28% Upside
688331
RemeGen Co Ltd
29% Downside
7774
Japan Tissue Engineering Co Ltd
86% Upside
IVA
Inventiva SA
225% Upside
MIRM
Mirum Pharmaceuticals Inc
35% Upside

Revenue
Forecast

Revenue Estimate
Oxford BioMedica PLC

For the last 13 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 3 years is 25%.

24%
Past Growth
25%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OXB's stock price target?
Price Target
526.32 GBX

According to Wall Street analysts, the average 1-year price target for OXB is 526.32 GBX with a low forecast of 383.8 GBX and a high forecast of 840 GBX.

What is Oxford BioMedica PLC's Revenue forecast?
Projected CAGR
25%

For the last 13 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 3 years is 25%.

Back to Top